India to Canada: Acyclovir Export Trade Route
India has recorded 90 verified shipments of Acyclovir exported to Canada, representing a combined trade value of $14.9M USD. This corridor is served by 13 active Indian exporters, with an average shipment value of $165.0K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 79% of total export value with 13 shipments worth $11.8M USD. On the buying side, MYLAN PHARMACEUTICALS ULC is the largest importer in Canada with $11.2M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, V S INTERNATIONAL PRIVATE LIMITED, AUROBINDO PHARMA LTD — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Acyclovir corridor is one of India's established pharmaceutical export routes, with 90 shipments documented worth a combined $14.9M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's acyclovir manufacturing sector.
Across 13 active suppliers, the average shipment value stands at $165.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with acyclovir's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 40 days port-to-port. The route has recorded an annual growth rate of 26.8%, placing it at rank #10 among India's top acyclovir export destinations globally.
On the import side, key buyers of Indian acyclovir in Canada include MYLAN PHARMACEUTICALS ULC, JAMP PHARMA CORPORATION, AURO PHARMA INC and 21 others. MYLAN PHARMACEUTICALS ULC is the single largest importer with 10 shipments valued at $11.2M USD.
